A combinatorially regulated RNA splicing signature predicts breast cancer EMT states and patient survival.
Ontology highlight
ABSTRACT: During breast cancer metastasis, the developmental process epithelial-mesenchymal transition (EMT) is abnormally activated. Transcriptional regulatory networks controlling EMT are well-studied; however, alternative RNA splicing also plays a critical regulatory role during this process. A comprehensive understanding of alternative splicing (AS) and the RNA binding proteins (RBPs) that regulate it during EMT and their impact on breast cancer remains largely unknown. In this study, we annotated AS in the breast cancer TCGA data set and identified an AS signature that is capable of distinguishing epithelial and mesenchymal states of the tumors. This AS signature contains 25 AS events, among which nine showed increased exon inclusion and 16 showed exon skipping during EMT. This AS signature acc
SUBMITTER: Qiu Y
PROVIDER: S-EPMC7430667 | biostudies-literature | 2020 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA